• Home
  • Technology
    • The platform
    • Artificial Intelligence
    • BioClick
    • Nobel Prize heritage
    • Biosolution phases
    • Scientific papers
    • Patents
  • Pipeline
    • Pipeline overview
    • NCT: Over-the-Counter
    • NCT: Pharma
    • Cannabinoids
    • Santalene
    • Become a partner
  • Investors
    • Stock information
    • News
    • Email signup
    • Investor Relation Contacts
    • Governance
    • SEC Filings
    • Video
  • About
    • Leadership team
    • History
    • Jobs
    • Contact
  • News
    • Latest news
    • Media coverage
    • Investor news
eXoZymes
Home

Technology

The platform Artificial Intelligence BioClick Scientific papers

Pipeline

Pipeline overview NCT: Over-the-Counter NCT: Pharma Cannabinoids Santalene

Investors

Stock information SEC Filings Email signup

About

About eXoZymes Jobs News
  1. Home
  2. General

Category

General

7 videos

Introducing our new CCO: Damien Perriman
investors
Introducing our new CCO: Damien Perriman April 02, 2025 · 155 views
Fox Business interview with CEO Michael Heltzen
investors
Fox Business interview with CEO Michael Heltzen March 13, 2025 · 122 views
How eXoZymes started: Interviews with Tyler Korman and Paul Opgenorth
interview
How eXoZymes started: Interviews with Tyler Korman and Paul Opgenorth March 10, 2025 · 73 views
Nasdaq tower: An hour of eXoZymes
General
Nasdaq tower: An hour of eXoZymes February 24, 2025 · 55 views
CNBC closing bell footage from Feb 19, 2025
investors
CNBC closing bell footage from Feb 19, 2025 February 21, 2025 · 35 views
Nasdaq tower: enzymes x AI = exozymes
General
Nasdaq tower: enzymes x AI = exozymes February 20, 2025 · 95 views
The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth
interview
The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth May 22, 2024 · 1,281 views

eXoZymes Inc.

750 Royal Oaks Dr, st 106, 
Monrovia 91016, CA, USA

P: (626) 415-1488
E: info@exozymes.com

 

© eXoZymes Inc. [Nasdaq:EXOZ] unshackling enzymes since 2019 (formerly known as Invizyne Technologies)

Videos Webinars Investors SEC Filings Privacy Policy Terms of Use